NASDAQ:RPRX | Income Statement | Royalty Pharma plc

Complete source-backed income-statement history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$674.14M$97.85M$133.12M-$51.63M$81.49M$0.00$17.88M$0.04$0.04445,064,000556,896,000
2026-03-31$630.58M$39.79M$563.04M-$94.78M$468.26M$0.00$294.69M$0.67$0.67436,790,000556,837,000
2025-12-31$621.99M$50.5M$388.38M-$32.47M$355.91M$0.00$214.21M$0.50$0.50-480,000-2,299,000
2025-09-30$609.29M$50.5M$427.16M$17.06M$444.21M$0.00$288.22M$0.67$0.67431,887,000559,611,000
2025-06-30$578.67M$300.5M$209.8M-$117.16M$92.64M$0.00$32.18M$0.08$0.07423,514,000562,298,000
2025-03-31$568.25M$50.5M$534.18M-$99.75M$434.43M$0.00$239.35M$0.55$0.55435,480,000578,102,000
2024-12-31$593.64M$500,000.00$361.51M-$27.16M$334.35M$0.00$208.21M$0.47$0.47-900,000-1,575,000
2024-09-30$564.69M$500,000.00$735.07M$71.28M$806.36M$0.00$543.99M$1.22$1.21447,628,000592,726,000
2024-06-30$537.27M$500,000.00$269.63M-$75.25M$194.38M$0.00$102M$0.23$0.23451,020,000596,912,000
2024-03-31$567.98M$500,000.00-$73.77M$69.5M-$4.27M$0.00$4.78M$0.01$0.01448,623,000597,479,000
2023-12-31$596.07M$500,000.00$612.9M$104.69M$717.59M$0.00$494.34M$1.11$1.10-561,000-1,817,000
2023-09-30$536.31M$50.5M$151.44M-$29.37M$122.08M$0.00$72.11M$0.16$0.16448,439,000601,138,000
2023-06-30$538.2M$500,000.00$248.84M$102.5M$351.34M$0.00$227.63M$0.51$0.50450,405,000605,860,000
2023-03-31$683.97M$500,000.00$478.97M$30.12M$509.09M$0.00$340.76M$0.76$0.76445,612,000607,251,000
2022-12-31$565.75M$50.5M-$482.66M-$127.38M-$610.03M$0.00-$456.08M-$1.04-$1.041,421,000-169,237,000
2022-09-30$573.46M$25.5M$192.21M$28.2M$220.41M$0.00$142.65M$0.32$0.32439,293,000607,226,000
2022-06-30$535.96M$606,000.00$377.79M$113.81M$491.6M$0.00$304.5M$0.70$0.70436,318,000607,214,000
2022-03-31$562.05M$100.5M$219.72M-$91.64M$128.08M$0.00$51.76M$0.12$0.12433,956,000607,201,000
2021-12-31$575.7M$103.82M$153.42M-$99.75M$53.67M$0.00$7.9M$0.00$0.005,541,000-192,350,000
2021-09-30$585.77M$90.5M$303.05M-$81.26M$221.8M$0.00$101.93M$0.24$0.24428,230,000607,174,000
2021-06-30$554.96M$3.12M$744.95M$61.81M$806.76M$0.00$440.78M$1.08$1.08409,344,000607,163,000
2021-03-31$573.03M$2.64M$229.3M-$70.32M$158.98M$0.00$69.12M$0.18$0.18389,760,000607,148,000
2020-12-31$572.14M$7.78M$314.06M$52.57M$366.63M$0.00$171.09M$0.44$0.447,691,0007,699,000
2020-09-30$538.4M$5.1M$510.57M$113.69M$624.25M$0.00$290.63M$0.79$0.79369,999,000370,002,000
2020-06-30$510.93M$5.78M$409.35M$192.63M$601.98M$0.00$442.07M$0.09$0.09353,979,000353,980,000
2020-06-17$515.79M
2020-03-31$500.88M$7.64M$361.43M-$252.33M$109.1M$0.00$71.24M
2019-12-31$457.49M$15.87M$1.33B$114.61M$1.45B$0.00$1.42B
2019-09-30$464.28M$22.72M$532.5M-$92.47M$440.03M$0.00$408.98M
2019-06-30$457.61M$21.46M$327.86M-$149.09M$178.77M$0.00$151.71M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.38B$452M$1.56B-$235.33M$1.32B$0.00$770.95M$1.79$1.78429,801,000564,455,000
2024-12-31$2.26B$2M$1.29B$38.37M$1.33B$0.00$858.98M$1.92$1.91448,185,000594,108,000
2023-12-31$2.35B$52M$1.49B$207.94M$1.7B$0.00$1.13B$2.54$2.53447,601,000602,900,000
2022-12-31$2.24B$177.11M$307.07M-$77M$230.06M$0.00$42.83M$0.10$0.10437,963,000437,972,000
2021-12-31$2.29B$200.08M$1.43B-$189.51M$1.24B$0.00$619.73M$1.49$1.49414,794,000414,802,000
2020-12-31$2.12B$26.29M$1.6B$106.56M$1.7B$0.00$975.04M$1.32$1.32375,444,000375,455,000
2019-12-31$1.81B$83.04M$2.62B-$161.76M$2.46B$0.00$2.35B
2018-12-31$1.79B$392.61M$1.36B$153.41M$1.52B$0.00$1.38B

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.